Covalent Fragment-Based Ligand Discovery to Drug Refractory Targets
Time: 5:00 pm
day: Conference Day One
Details:
- How can covalent fragment-based ligand discovery be leveraged to tackle so-called undruggable targets?
- What are the advantages of a target-centric approach to covalent fragment-based ligand discovery?
- What approaches (biochemical and cell-based) can be deployed to progress covalent fragment starting points to mature lead molecules within a drug discovery campaign?
